Then it was decided to add additional blood work with tumor markers, CA 19-9 of 18 U/ml (NV < 37 U/ml) and carcinoembryonic antigen (CEA) of 2.3 ng/ml (NV < 3.8 ng/ml). This evidence concerns the gene CEACAM5 and neoplasm.